Noah Camp, PA
Physician Assistant · Jacksonville, NCNPI 1477060879
Payments from drug & device makers
Across 133 payments — averaging $15.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$288
- Lilly USA, LLC$267
- AstraZeneca$245
- Novo Nordisk$232
- GSK$127
- Merck$120
- plus $817 from 23 others
What the payments were for
- Food & beverage$2,08499%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $288 |
| Lilly USA, LLC | 19 | $267 |
| AstraZeneca | 14 | $245 |
| Novo Nordisk | 16 | $232 |
| GSK | 9 | $127 |
| Merck | 7 | $120 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $86 |
| Boston Scientific | 2 | $76 |
| Amgen | 4 | $63 |
| Currax Pharmaceuticals LLC | 4 | $49 |
| Pfizer | 3 | $48 |
| Biohaven Pharmaceuticals, Inc. | 3 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $47 |
| Medtronic | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 3 | $41 |
| Sunovion Pharmaceuticals Inc. | 4 | $40 |
| Boehringer Ingelheim | 3 | $39 |
| Exact Sciences | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Amarin Pharma, Inc. | 2 | $24 |
| Si-bone, Inc. | 1 | $23 |
| Grifols USA, LLC | 1 | $23 |
| Bioventus LLC | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Novartis | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $12 |
| Johnson & Johnson | 1 | $12 |
How this compares
$2,095 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 53 | $55,766 |
| TrulicityDulaglutide | 51 | $53,125 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 58 | $52,194 |
| FarxigaDapagliflozin Propanediol | 37 | $47,732 |
| OzempicSemaglutide | 45 | $42,317 |
| EliquisApixaban | 53 | $39,392 |
| RybelsusSemaglutide | 19 | $31,731 |
| XareltoRivaroxaban | 19 | $23,883 |
| JanumetSitagliptin Phos/Metformin Hcl | 14 | $15,615 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $15,199 |
| Spiriva RespimatTiotropium Bromide | 26 | $14,032 |
| Ramelteon | 20 | $3,783 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 37 | $3,541 |
| Atorvastatin Calcium | 283 | $2,560 |
| Rosuvastatin Calcium | 185 | $2,392 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $232 | $74,04764 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $39 | $69,79979 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $245 | $62,93160 claims |
| Lilly USA, LLCTrulicity | $267 | $53,12551 claims |
| GSKTrelegy Ellipta | $127 | $52,19458 claims |
| PfizerEliquis | $48 | $39,39253 claims |
| Johnson & JohnsonXarelto | $12 | $23,88319 claims |
| MerckJanumet | $120 | $15,61514 claims |
| AbbVieSynthroid | $288 | $1,24112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Jacksonville
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
- Jay ClarkeArden$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.